Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 463

1.

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.

Douros A, Dell'Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S.

BMJ. 2018 Jul 18;362:k2693. doi: 10.1136/bmj.k2693.

2.

Response to Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.

Suissa S.

Diabetes Care. 2018 Jun;41(6):e109-e110. doi: 10.2337/dci18-0015. No abstract available.

PMID:
29784709
3.

The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies.

Tran T, Suissa S.

Eur Respir J. 2018 Jun 21;51(6). pii: 1800376. doi: 10.1183/13993003.00376-2018. Print 2018 Jun.

PMID:
29724921
4.

Observational Studies of Inhaled Corticosteroid Effectiveness in COPD: Lessons Learned.

Suissa S, Ernst P.

Chest. 2018 Aug;154(2):257-265. doi: 10.1016/j.chest.2018.04.006. Epub 2018 Apr 19.

PMID:
29679596
5.

Making Sense of Triple Inhaled Therapy for COPD.

Suissa S, Drazen JM.

N Engl J Med. 2018 May 3;378(18):1723-1724. doi: 10.1056/NEJMe1716802. Epub 2018 Apr 18. No abstract available.

PMID:
29669218
6.

Reduced Mortality With Sodium-Glucose Cotransporter-2 Inhibitors in Observational Studies: Avoiding Immortal Time Bias.

Suissa S.

Circulation. 2018 Apr 3;137(14):1432-1434. doi: 10.1161/CIRCULATIONAHA.117.032799. No abstract available.

PMID:
29610125
7.

Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases.

Huiart L, Ferdynus C, Renoux C, Beaugrand A, Lafarge S, Bruneau L, Suissa S, Maillard O, Ranouil X.

BMJ Open. 2018 Mar 30;8(3):e018180. doi: 10.1136/bmjopen-2017-018180.

8.

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.

Douros A, Azoulay L, Yin H, Suissa S, Renoux C.

J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.

PMID:
29519351
9.

Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study.

Loo SY, Coulombe J, Dell'Aniello S, Brophy JM, Suissa S, Renoux C.

BMJ Open. 2018 Jan 24;8(1):e019638. doi: 10.1136/bmjopen-2017-019638.

10.

Reply to P. Autier et al.

Suissa S, Azoulay L.

J Clin Oncol. 2018 Mar 10;36(8):831-832. doi: 10.1200/JCO.2017.77.0057. Epub 2018 Jan 25. No abstract available.

PMID:
29369706
11.

Mortality Reduction in EMPA-REG OUTCOME Trial: Beyond the Antidiabetes Effect.

Suissa S.

Diabetes Care. 2018 Feb;41(2):219-223. doi: 10.2337/dc17-1059.

PMID:
29358464
12.

Food and Drug Administration-mandated Trials of Long-Acting β-Agonist Safety in Asthma. Bang for the Buck?

Suissa S, Israel E, Donohue J, Evans S, Kemp J.

Am J Respir Crit Care Med. 2018 Apr 15;197(8):987-990. doi: 10.1164/rccm.201709-1940PP. No abstract available.

PMID:
29357261
13.

Effect of Cesarean Delivery on Long-term Risk of Small Bowel Obstruction.

Abenhaim HA, Tulandi T, Wilchesky M, Platt R, Spence AR, Czuzoj-Shulman N, Suissa S.

Obstet Gynecol. 2018 Feb;131(2):354-359. doi: 10.1097/AOG.0000000000002440.

PMID:
29324607
14.

Proton-pump inhibitors and increased gastric cancer risk: time-related biases.

Suissa S, Suissa A.

Gut. 2018 Jan 3. pii: gutjnl-2017-315729. doi: 10.1136/gutjnl-2017-315729. [Epub ahead of print] No abstract available.

PMID:
29298870
15.

Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?

Suissa S.

Diabetes Care. 2018 Jan;41(1):6-10. doi: 10.2337/dc17-1223.

PMID:
29263192
16.

Comparative effect of statins on the risk of incident Alzheimer disease.

Sinyavskaya L, Gauthier S, Renoux C, Dell'Aniello S, Suissa S, Brassard P.

Neurology. 2018 Jan 16;90(3):e179-e187. doi: 10.1212/WNL.0000000000004818. Epub 2017 Dec 15.

PMID:
29247073
17.

Temporal trends in outpatient management of incident pulmonary embolism and associated mortality.

Klil-Drori AJ, Coulombe J, Suissa S, Hirsch A, Tagalakis V.

Thromb Res. 2018 Jan;161:111-116. doi: 10.1016/j.thromres.2017.10.026. Epub 2017 Nov 6.

PMID:
29132688
18.

Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study.

Simon TA, Kawabata H, Ray N, Baheti A, Suissa S, Esdaile JM.

Adv Ther. 2017 Nov;34(11):2481-2490. doi: 10.1007/s12325-017-0627-3. Epub 2017 Oct 24.

19.

Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.

Yu O, Azoulay L, Yin H, Filion KB, Suissa S.

Am J Med. 2018 Mar;131(3):317.e11-317.e22. doi: 10.1016/j.amjmed.2017.09.044. Epub 2017 Oct 12.

PMID:
29032229
20.

Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study.

Douros A, Renoux C, Coulombe J, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1546-1554. doi: 10.1002/pds.4333. Epub 2017 Oct 6.

PMID:
28984052
21.

Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes.

Wu JW, Azoulay L, Majdan A, Boivin JF, Pollak M, Suissa S.

J Clin Oncol. 2017 Nov 10;35(32):3647-3653. doi: 10.1200/JCO.2017.73.4491. Epub 2017 Sep 27.

PMID:
28953430
22.

The FULFIL Trial.

Suissa S, Ariel A.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):542. doi: 10.1164/rccm.201708-1578LE. No abstract available.

PMID:
28950066
23.

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S.

Diabetes Care. 2017 Nov;40(11):1506-1513. doi: 10.2337/dc17-0595. Epub 2017 Sep 1.

PMID:
28864502
24.

Precision Medicine Urgency: The Case of Inhaled Corticosteroids in COPD.

Suissa S, Ernst P.

Chest. 2017 Aug;152(2):227-231. doi: 10.1016/j.chest.2017.05.020. No abstract available.

PMID:
28797382
25.

Long-term Use of Inhaled Corticosteroids in COPD and the Risk of Fracture.

Gonzalez AV, Coulombe J, Ernst P, Suissa S.

Chest. 2018 Feb;153(2):321-328. doi: 10.1016/j.chest.2017.07.002. Epub 2017 Jul 14.

PMID:
28716642
26.

Run-in bias in randomised trials: the case of COPD medications.

Suissa S.

Eur Respir J. 2017 Jun 22;49(6). pii: 1700361. doi: 10.1183/13993003.00361-2017. Print 2017 Jun. No abstract available.

PMID:
28642311
27.

Sex, breathing and statistics.

Suissa S, Gonzalez AV, Shrier I.

Eur Respir J. 2017 May 25;49(5). pii: 1700455. doi: 10.1183/13993003.00455-2017. Print 2017 May. No abstract available.

PMID:
28546264
28.

Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events.

Suissa S, Dell'Aniello S, Ernst P.

Eur Respir J. 2017 May 23;49(5). pii: 1602245. doi: 10.1183/13993003.02245-2016. Print 2017 May.

PMID:
28536251
29.

Sulfonylureas and the Risks of Cardiovascular Events and Death: A Methodological Meta-Regression Analysis of the Observational Studies.

Azoulay L, Suissa S.

Diabetes Care. 2017 May;40(5):706-714. doi: 10.2337/dc16-1943. Review.

PMID:
28428321
30.

Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study.

Qian CJ, Coulombe J, Suissa S, Ernst P.

Br J Clin Pharmacol. 2017 Sep;83(9):2077-2086. doi: 10.1111/bcp.13295. Epub 2017 May 7.

PMID:
28425216
31.

Metformin and the incidence of viral associated cancers in patients with type 2 diabetes.

Hicks BM, Yin H, Sinyavskaya L, Suissa S, Azoulay L, Brassard P.

Int J Cancer. 2017 Jul 1;141(1):121-128. doi: 10.1002/ijc.30733. Epub 2017 Apr 24.

32.

Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.

Larivée N, Suissa S, Coulombe J, Tagalakis V, Filion KB.

Drug Saf. 2017 Jul;40(7):583-596. doi: 10.1007/s40264-017-0525-2.

PMID:
28382493
33.

Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.

Renoux C, Dell'Aniello S, Brenner B, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 May;26(5):554-560. doi: 10.1002/pds.4197. Epub 2017 Mar 22.

PMID:
28326633
34.

Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.

Larivée N, Suissa S, Khosrow-Khavar F, Tagalakis V, Filion KB.

BJOG. 2017 Sep;124(10):1490-1499. doi: 10.1111/1471-0528.14623. Epub 2017 May 5. Review. Erratum in: BJOG. 2018 Jun;125(7):910.

PMID:
28276140
35.

Influenza Vaccination and Stillbirth Prevention in High-Income Countries: Is It Really That Effective?

Levi M, Ravaldi C, Pontello V, Bonaiuti R, Vannacci A, Suissa S.

Clin Infect Dis. 2017 Apr 15;64(8):1142-1143. doi: 10.1093/cid/cix107. No abstract available.

PMID:
28199508
36.

Metformin to Treat Cancer: Misstep in Translational Research from Observational Studies.

Suissa S.

Epidemiology. 2017 May;28(3):455-458. doi: 10.1097/EDE.0000000000000634. No abstract available.

PMID:
28166103
37.

Statins in Multiple Myeloma: Survival Benefit or Immortal Time Bias?

Suissa S, Klil-Drori AJ.

J Clin Oncol. 2017 Apr 20;35(12):1377-1378. doi: 10.1200/JCO.2016.70.9725. Epub 2017 Feb 6. No abstract available.

PMID:
28165910
38.

Revisiting sex differences in outcomes in non-valvular atrial fibrillation: a population-based cohort study.

Renoux C, Coulombe J, Suissa S.

Eur Heart J. 2017 May 14;38(19):1473-1479. doi: 10.1093/eurheartj/ehw613.

PMID:
28073863
39.

Effectiveness of Fluticasone Furoate-Vilanterol in COPD.

Suissa S.

N Engl J Med. 2016 Dec 29;375(26):2606. doi: 10.1056/NEJMc1613713. No abstract available.

PMID:
28029916
40.

The Risk of Sepsis with Inhaled and Oral Corticosteroids in Patients with COPD.

Ernst P, Coulombe J, Brassard P, Suissa S.

COPD. 2017 Apr;14(2):137-142. doi: 10.1080/15412555.2016.1238450. Epub 2016 Dec 23.

PMID:
28010132
41.

Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Khosrow-Khavar F, Filion KB, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, Azoulay L.

Ann Oncol. 2017 Mar 1;28(3):487-496. doi: 10.1093/annonc/mdw673. Review.

42.

Identifying Causes for Excess Mortality in Patients With Diabetes: Closer but Not There Yet.

Yu OH, Suissa S.

Diabetes Care. 2016 Nov;39(11):1851-1853. No abstract available.

PMID:
27926885
43.

Testosterone treatment and risk of venous thromboembolism: population based case-control study.

Martinez C, Suissa S, Rietbrock S, Katholing A, Freedman B, Cohen AT, Handelsman DJ.

BMJ. 2016 Nov 30;355:i5968. doi: 10.1136/bmj.i5968.

44.

Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study.

Tascilar K, Dell'Aniello S, Hudson M, Suissa S.

Arthritis Rheumatol. 2016 Nov;68(11):2603-2611. doi: 10.1002/art.39774.

45.

Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study.

Larivée N, Suissa S, Eberg M, Joseph L, Eisenberg MJ, Abenhaim HA, Filion KB.

BJOG. 2017 Oct;124(11):1672-1679. doi: 10.1111/1471-0528.14358. Epub 2016 Oct 5.

PMID:
27704723
46.

The effect of statins on influenza-like illness morbidity and mortality.

Brassard P, Wu JW, Ernst P, Dell'Aniello S, Smiechowski B, Suissa S.

Pharmacoepidemiol Drug Saf. 2017 Jan;26(1):63-70. doi: 10.1002/pds.4112. Epub 2016 Sep 30.

PMID:
27686457
47.

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal.

Yawn BP, Suissa S, Rossi A.

NPJ Prim Care Respir Med. 2016 Sep 29;26:16068. doi: 10.1038/npjpcrm.2016.68. Review.

48.

Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores.

Suissa S, Moodie EE, Dell'Aniello S.

Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):459-468. doi: 10.1002/pds.4107. Epub 2016 Sep 9.

PMID:
27610604
49.

Indacaterol-Glycopyrronium for COPD.

Suissa S.

N Engl J Med. 2016 Sep 1;375(9):897-8. doi: 10.1056/NEJMc1609305. No abstract available.

PMID:
27579648
50.

The Use of Telmisartan and the Incidence of Cancer.

Tascilar K, Azoulay L, Dell'Aniello S, Bartels DB, Suissa S.

Am J Hypertens. 2016 Dec 1;29(12):1358-1365. doi: 10.1093/ajh/hpw095.

Supplemental Content

Loading ...
Support Center